|
|
LifeCell Corporation - Comparative Business Analysis Snapshot
Business Description
LifeCell Corporation. The Company's principal activity is to develop and market biologically based solutions for the repair and replacement of damaged or inadequate human tissues in different clinical applications. The Company's patented tissue-processing technology produces a regenerative tissue matrix, which is a complex three-dimensional structure that contains vascular channels, proteins and growth factor-binding sites that provides a complete template for the regeneration of normal human tissue. The products of the Company include: AlloDerm for plastic reconstructive, burn and periodontal procedures; Cymetra for non-surgical correction of soft tissue defects; Repliform for urology and gynecology procedures; cryopreserved allograft skin for use as a temporary wound dressing in the treatment of burns; Cymetra, a version of AlloDerm in particulate form; Repliform for urogynecologic procedures; Graft Jacket for orthopedic applications and Allocratf DBM for bone grafting.
Competitor Analysis
This analysis compares LifeCell Corporation with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
